SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-20-000116
Accepted
2020-01-21 00:15:17
Documents
1
Effectiveness Date
2020-01-17
Registration Form
POS AM
Reference AccNo

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 610
  Complete submission text file 9999999995-20-000116.txt   1737
Mailing Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108
Business Address 600 CALIFORNIA ST., 17TH FLOOR SAN FRANCISCO CA 94108 415-638-6556
Audentes Therapeutics, Inc. (Filer) CIK: 0001628738 (see all company filings)

IRS No.: 461606174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-222680 | Film No.: 20534937
SIC: 2836 Biological Products, (No Diagnostic Substances)